𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HOXgene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells

✍ Scribed by Namhyun Chung; Bo Keun Jee; Song Wha Chae; Yang-Whan Jeon; Kweon Haeng Lee; Hyoung Kyun Rha

Publisher
Springer
Year
2007
Tongue
English
Weight
426 KB
Volume
36
Category
Article
ISSN
0301-4851

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Human peripheral blood derived mesenchym
Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells
✍ Pan-Pan Chong; Lakshmi Selvaratnam; Azlina A. Abbas; Tunku Kamarul πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 928 KB

## Abstract The use of mesenchymal stem cells (MSCs) for cartilage repair has generated much interest owing to their multipotentiality. However, their significant presence in peripheral blood (PB) has been a matter of much debate. The objectives of this study are to isolate and characterize MSCs de

Chondrogenesis of human bone marrow-deri
Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture
✍ Charles Huang, C.-Y. ;Reuben, Paul M. ;D'Ippolito, Gianluca ;Schiller, Paul C. ; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 567 KB

## Abstract Mesenchymal stem cells derived from human bone marrow (hBM‐MSCs) can differentiate into chondrogenic cells for the potential treatment of injured articular cartilage. To evaluate agarose gels as a supportive material for chondrogenesis of hBM‐MSCs, this study examined chondrogenesis of

Adenoviral expression of vascular endoth
Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells
✍ Huey Lin; Arsalan Shabbir; Merced Molnar; Jingwei Yang; Susan Marion; John M. Ca πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 423 KB

## Abstract Bone marrow‐derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)‐based gene therapy protocols have been used to tre